Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms
Recruiting now · Not applicable
Conditions studied: Gastrointestinal Neoplasms
In brief
The primary objective: association study of characteristics of tumoral microenvironment and immunity of digestive cancers with patients' overall survival (OS).
Key facts
- Study ID
- NCT04363983
- Run by
- Assistance Publique - Hôpitaux de Paris
- People needed
- 6300
- Starts
- 2021-01-13
- Expected to finish
- 2031-01-01
- Last updated by the study team
- 2022-02-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Carcinoma of colorectal, pancreatic, biliary tract or gastro-oesophageal, or neuroendocrine digestive tumors with cytologically or histologically proven, regardless of the stage;
- Diagnosis between 1998 and 2030;
- Be >/= 18 years;
- Have obtained signed informed consent (exemption for dead patients);
- Affiliated to the French social security - welfare system in France (CMU included).
You may not qualify if…
- Patient under tutoraship or curatorship;
- Foreign patient under AME schema, a medical help from the state in France;
- Pregnant or breastfeeding women (for prospective study);
- Any clinical, psychological or social reason which should influence patient compliance with protocol, according to investigator;
- Patient refusal.
Where it is running
- Digestive Surgery Department, Ambroise Paré Hospital, APHP — Boulogne-Billancourt, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.